Stock Events

Stock Events

CRISPR Therapeutics (C2RS34.SA) Q1 2025 Earnings

11FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-8.52

-6.53

-4.53

-2.54

Details

Expected EPS

-6.921112338

Actual EPS

-2.53638

Surprise EPS

4.38

Surprise Percent

+63.35%

Description

CRISPR Therapeutics (C2RS34.SA) has reported earnings of -2.53638 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.